The At4g16820 Antibody is a molecular tool designed to detect the protein encoded by the Arabidopsis thaliana gene At4g16820, a phospholipase A I beta 2 (PLA-Iβ2) enzyme. This gene, also known as DALL1 (Defective in Anther Dehiscence 1-like Lipase 1), encodes a lipase involved in lipid metabolism, stress responses, and jasmonic acid (JA) biosynthesis. The antibody facilitates research into its role in membrane lipid processing, plant defense, and lipid-based signaling pathways .
The At4g16820 protein belongs to the alpha/beta-Hydrolases superfamily and hydrolyzes phosphatidylcholine, glycolipids (e.g., MGDG, DGDG), and triacylglycerols (TAGs) . Key functions include:
Lipid Metabolism: Catalyzing the release of free fatty acids (FFAs) from membrane lipids, which are precursors for oxylipin signaling molecules like JA .
Stress Responses: Participating in wound-induced JA biosynthesis and salt stress adaptation .
Lipid Signaling: Facilitating lipid transport in phloem exudates, potentially enabling long-distance signaling .
The antibody is used to immunodetect At4g16820 protein levels in tissues under stress (e.g., wounding, salinity) or during developmental processes. For example:
Western Blotting: Validates protein expression in mutants or transgenic plants. In PDEX:AtDAD1-Myc lines, Myc-tagged DAD1-like proteins are analyzed to study lipid remodeling .
Immunolocalization: Identifies subcellular localization (e.g., chloroplasts, membranes) .
Studies using antibodies to detect related lipases (e.g., DAD1) reveal:
TAG Accumulation: Overexpression of DAD1-like enzymes redirects fatty acids into TAGs via PDAT1/DGAT1 pathways .
Lipid Profiling: MGDG (18:3/18:3) and DGDG (36:6) levels decrease post-treatment, while LysoPC species accumulate .
COI1 Dependency: In dgd1 mutants, At4g16820 activity is influenced by COI1-mediated JA feedback loops, altering LOX/AOC enzyme levels .
Pathway Crosstalk: Contributes to JA biosynthesis alongside PLA-Iγ3 and LOX enzymes .
Specificity: The antibody may cross-react with related lipases (e.g., DAD1), requiring validation via peptide blocking or mutant controls .
Tissue Optimization: Highest expression in leaves and flowers, with induced levels in roots under stress .
Commercial Availability: Limited to custom synthesis, as no commercial antibody is explicitly reported in literature.
KEGG: ath:AT4G16820
STRING: 3702.AT4G16820.1
Here’s a structured FAQ for researchers investigating the At4g16820 Antibody in Arabidopsis thaliana studies, incorporating methodological guidance and data-driven insights:
Use immunolocalization to track subcellular redistribution of At4g16820 under high-salinity conditions (e.g., 150 mM NaCl) .
Pair with qRT-PCR to correlate protein abundance with transcriptional changes in related pathways (e.g., SOS1, SOS3) .
Integrate with ChIP-seq to identify DNA-binding targets under stress .
At4g16820 may interact with HDAC inhibitors (e.g., Ky-9/Ky-72) but not SOS pathway components, suggesting alternative regulatory mechanisms .
Case Example:
In HDAC inhibitor studies, At4g16820 protein increased despite unchanged mRNA, implicating post-translational regulation .
Isotype-matched IgG to exclude nonspecific binding
Bait-only lysate (transfected empty vector)
Pre-immune serum from the same host species
Cross-adsorption: Pre-incubate with A. thaliana protein extracts to remove species-specific cross-reactivity .
Signal Amplification: Combine tyramide-based amplification with ≤2 other fluorophores (e.g., Alexa 488/647).
Validation: Compare staining patterns across developmental stages using CLSM with Airyscan detection .
Map protein localization data to AraPPIS (Arabidopsis Protein-Protein Interaction Server)
Overlay with RNA-seq clusters using STEM (Short Time-series Expression Miner)
Predict regulatory hierarchies via SDREM (Stochastic Discrete Regulation Modeling)
Key Finding:
At4g16820 clusters with pathogen-response modules but not ion homeostasis pathways, aligning with its absence in SOS1/3 regulation .